PharVision Advisers »

Rev shares owned by PharVision Advisers

Quarter-by-quarter ownership of Rev (REVG) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Rev

Tip: Access up to 7 years of quarterly data

All positions including Rev held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rev by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $365k 6.4k 56.67

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Rev

FMR
Vanguard Group
BlackRock
Hanna Zanoni
Neuberger Berman Group
Geode Capital Management
High Ground Investment Management
State Street Corporation
Capital Research Global Investors
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
Invesco
American Century Companies
Segall Bryant & Hamill
Wellington Management Company

View all funds holding Rev